Targagenix INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersStony Brook, NY
US patents4
SAM.gov UEIK16KV87JHNY4
CAGE code9MN96
Incorporated inDE
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
4 US patents granted 2019–2025, 3 of them in the five years to SEP 2025.
Pharmaceuticals 3
- Combination taxoid nanoemulsion with immunotherapy in cancerUS 12,186,428 · granted JAN 7, 2025
- Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cancer cells and cancer stem cellsUS RE50096 · granted AUG 27, 2024
- Combination taxoid nanoemulsion with immunotherapy in cancerUS 11,497,713 · granted NOV 15, 2022
- Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cancer cells and cancer stem cellsUS 10,206,875 · granted FEB 19, 2019
Granted to TargaGenix, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Targagenix INC. | Stony Brook | NY | — | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.
